Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CHICAGO , Aug. 29, 2022 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today launched Bitcoin Euro and Ether Euro futures. "The launch of these new futures contracts builds on the strong growth and deep liquidity we have seen in our existing U.S. dollar-denominated Bitcoin and Ether futures contracts," said Tim McCourt, Global Head of Equity and FX Products, CME Group.

CME Group Announces Launch of Euro-denominated Bitcoin and Ether Futures

CHICAGO , Aug. 22, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, is calling on global college students interested in pursuing careers in finance and markets to register for its annual University Trading Challenge which will be held during October 2022. Registration for the global educational competition opens today.

CME Group Opens Registration for its 19th Annual Global University Trading Challenge 2022

More than $2.5 million in Foundation scholarships awarded since 2019 Students eligible for $20,000 in grants each year for up to three years CHICAGO , Aug. 11, 2022 /PRNewswire/ -- CME Group Foundation today announced that 18 rising Black and Latinx students majoring in finance, technology and related fields at 11 partner colleges and universities in Illinois have been awarded $20,000 in scholarships each to further their education. While many scholarship programs are aimed at helping freshmen start college, the CME Group Foundation Scholarship Program works to ensure that sophomores, juniors, and seniors can finish their four-year degrees.

CME Group Foundation Awards 2022 Higher Education Scholarships to Rising Black and Latinx Students

Demand for currency derivatives has shot up this year, data from CME Group showed on Wednesday, in a sign investors are positioning for hefty interest rate hikes from the U.S. Federal Reserve and other big central banks.

Demand for FX derivatives jumps as central banks prep rate rises- CME Group

CHICAGO , Aug. 9, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its suite of CME Group Volatility Indexes (CVOL) are now streaming in real-time, allowing investors to keep an up to the minute pulse on what nearly every major market is signaling about future risk. "In today's uncertain global economy, the ability to track volatility across multiple asset classes has never been more important so we are pleased to make our CVOL indexes available in real-time," said Derek Sammann, Senior Managing Director and Global Head of Commodities, Options and International Markets at CME Group.

Market Participants Can Now Gauge Volatility in Real-Time with CME Group's Live Streaming CVOL Indexes

CHICAGO , Aug. 5, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will launch European Overnight Index futures based on RepoFunds Rate (RFR) benchmarks and the Euro Short-Term Rate (€STR) in Q4 2022, pending regulatory review. RFR futures will be cash-settled contracts based on RFR benchmarks, a robust measure of overnight funding costs.

CME Group Announces Q4 2022 Launch of European Overnight Index Futures

CHICAGO , Aug. 2, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that CME Clearing has further expanded the collateral it accepts and now will permit clearing members to deposit Short-Term U.S. Treasury Exchange Traded Funds (ETFs) to meet initial margin requirements. CME Clearing accepts the widest range of collateral of any major clearing house.

CME Clearing Expands Collateral Policy to Accept Short-Term U.S. Treasury ETFs

40% growth in Equity Index ADV, driven by micro and E-mini contracts Record SOFR options and futures OI on July 29 CHICAGO , August 2, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its July 2022 market statistics, showing average daily volume (ADV) increased 20% to 20.4 million contracts during the month. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.

CME Group Reports 20% ADV Growth in July 2022

CME Group, the world's largest derivatives exchange operator, offers investors a high yield and more than decent long-term growth. The company is mature, but it benefits from a dominant position in all of its business segments and fast growth in new products like SOFR.

CME Dividends Are Highly Attractive

CME Group (CME) Q2 results reflect higher revenues and lower expenses.

CME Group (CME) Q2 Earnings, Revenues Top Estimates, Rise Y/Y

CME Group Inc. (NASDAQ:CME ) Q2 2022 Earnings Conference Call July 27, 2022 8:30 AM ET Company Participants John Peschier - Investor Relations Terry Duffy - Chairman & Chief Executive Officer John Pietrowicz - Chief Financial Officer Lynne Fitzpatrick - Senior Managing Director & Deputy Chief Financial Officer Sean Tully - Senior Managing Director, Financial and OTC Products Derek Sammann - Senior Managing Director, Commodity & Options Products Julie Winkler - Chief Commercial Officer Sunil Cutinho - President, CME Clearing Conference Call Participants Rich Repetto - Piper Sandler Alex Kramm - UBS Dan Fannon - Jefferies Brian Bedell - Deutsche Bank Gautam Sawant - Credit Suisse Alex Blostein - Goldman Sachs Mike Cyprys - Morgan Stanley Owen Lau - Oppenheimer Kyle Voigt - KBW Patrick O'Shaughnessy - Raymond James Craig Siegenthaler - Bank of America Operator Good day and welcome to the CME Group Second Quarter 2022 Earnings Call. At this time, I would like to turn the conference over to John Peschier.

CME Group Inc. (CME) CEO Terry Duffy on Q2 2022 Results - Earnings Call Transcript

CME (CME) delivered earnings and revenue surprises of 2.60% and 0.77%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CME Group (CME) Q2 Earnings Beat Estimates

CHICAGO , July 27, 2022 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2022. The company reported revenue of $1.2 billion and operating income of $750 million for the second quarter of 2022.

CME Group Inc. Reports Second-Quarter 2022 Financial Results

CME Group (NASDAQ: CME) is scheduled to report its fiscal Q2 2021 results on Wednesday, July 27, 2022. We expect CME Group﻿﻿ to edge past the consensus estimates of revenues and earnings.

CME Group Stock To Edge Past Expectations In Q2?

CHICAGO , July 25, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that open interest in Copper options surpassed 100,000 contracts on July 21, 2022, reaching an all-time record after multiple back-to-back open interest record days throughout the week. "Seen as a bellwether for the global economy, market users are turning to our Copper options to manage risk as expectations for an economic slowdown continue to increase," said Jin Chang, Global Head of Metals at CME Group.

CME Group Announces Record Copper Options Open Interest

CME Group's (CME) Q2 earnings is likely to reflect improved clearing, transaction fees and other revenues, and market data and information services, weighed on by higher expenses.

CME Group (CME) to Report Q2 Earnings: What's in the Offing?

CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why CME (CME) is Poised to Beat Earnings Estimates Again

LONDON and SINGAPORE , July 12, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached 6.3 million contracts in Q2 2022, up 21% year on year.  Reflecting all trading reported from outside the United States, volume was driven largely by 43% growth in Equity Index products, a 28% increase in Interest Rate products, a 24% rise in Foreign Exchange products and a 44% growth in Equity Options.

CME Group International Average Daily Volume Reached 6.3 Million Contracts in Q2 2022, Up 21% from Q2 2021

CHICAGO , July 11, 2022 /PRNewswire/ -- CME Group Chairman and CEO Terry Duffy today issued the following statement on behalf of the company: "The futures industry lost a great leader with the passing of John O'Brien, Sr., who was a Board member, former Chairman and former CEO, as well as a founding family member of RJO & Associates, the oldest and largest independent futures brokerage and clearing firm in the U.S.," said CME Group Chairman and Chief Executive Officer Terry Duffy. "John spent his career championing the U.S. futures industry and was instrumental in expanding its reach to customers around the world.

Statement by CME Group Chairman and Chief Executive Officer Terry Duffy on John W. O'Brien, Sr.

American Tower

Sometimes a premium multiple is warranted due to a company's competitive position.

2 Hot Stocks That Can Live Up to Their Lofty Valuations

CME Group's stock (NASDAQ: CME) has lost 9% YTD, while the S&P500 is down 18% over the same period.

Is CME Group Stock Undervalued?

CHICAGO , July 7, 2022 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced plans to expand its suite of Sector futures with the addition of six new contracts on August 8, pending regulatory review. These new contracts will include: E-mini S&P Regional Banks Select Industry futures E-mini S&P Insurance Select Industry futures E-mini S&P Biotechnology Select Industry futures E-mini S&P Oil & Gas Exploration and Production Select Industry futures E-mini S&P Retail Select Industry futures E-mini PHLX Semiconductor Sector Index futures "We continue to see strong market demand for liquid, cost-effective and capital-efficient tools to track the same underlying indices as some of the most popular ETFs," said Tim McCourt, CME Group Global Head of Equity and FX Products.

CME Group to Launch Six New E-mini Sector Index Futures on August 8

Highest-ever June ADV, with Q2 volume up 25% year-over-year Q2 Equity Index ADV grew 57%, including record Micro E-Mini S&P 500 futures volume Record SOFR futures and options ADV, OI CHICAGO , July 5, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its Q2 and June 2022 market statistics, showing average daily volume (ADV) increased 25% to 23.1 million contracts during the second quarter, the company's third-highest quarterly volume ever. June ADV increased 30% to 24 million contracts, representing the company's highest June volume on record.

CME Group Reports Q2 and June 2022 Market Statistics

CHICAGO , June 28, 2022 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced it will launch event contracts on September 19, pending regulatory review. Designed especially for the retail audience, these contracts will allow individuals to trade their views on daily up or down price moves in some of the world's most widely quoted benchmark futures markets, beginning with E-mini S&P 500, E-mini Nasdaq-100, E-mini Dow Jones Industrial Average, E-mini Russell 2000, crude oil, natural gas, gold, silver, copper and Euro FX.

CME Group to Launch Event Contracts on September 19

CHICAGO , June 28, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will add two new futures contracts to its suite of voluntary carbon products, which have quickly found market adoption since launching last year.   The CBL N-GEO Trailing and CBL C-GEO Trailing futures contracts will be available for trading on August 8, 2022, pending regulatory review, allowing clients to trade offset credits that are no longer within the eligibility window of the existing CBL N-GEO and CBL C-GEO contracts.

News for CME Group Stock (CME)